ARG52396
anti-PLK1 phospho (Thr210) antibody
anti-PLK1 phospho (Thr210) antibody for Western blot and Human,Rat
Cancer antibody; Cell Biology and Cellular Response antibody; Gene Regulation antibody
Overview
Product Description | Rabbit Polyclonal antibody recognizes PLK1 phospho (Thr210) |
---|---|
Tested Reactivity | Hu, Rat |
Predict Reactivity | Ms, Bov, Dog, NHuPrm, Xenopus laevis, Zfsh |
Tested Application | WB |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | IgG |
Target Name | PLK1 |
Antigen Species | Human |
Immunogen | Synthetic phospho-peptide corresponding to amino acid residues surrounding Thr210 conjugated to KLH |
Conjugation | Un-conjugated |
Alternate Names | STPK13; Serine/threonine-protein kinase PLK1; EC 2.7.11.21; Serine/threonine-protein kinase 13; Polo-like kinase 1; PLK-1; PLK |
Application Instructions
Application Suggestion |
|
||||
---|---|---|---|---|---|
Application Note | Specific for ~66k PLK phosphorylated at Thr 210. Immunolabeling of the PLK band is completely blocked by λ-phosphatase treatment. * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. |
Properties
Form | Liquid |
---|---|
Purification | Affinity Purified |
Buffer | 10 mM HEPES (pH 7.5), 150 mM NaCl, 0.1 mg/ml BSA and 50% Glycerol |
Stabilizer | 0.1 mg/ml BSA, 50% Glycerol |
Storage Instruction | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
Database Links |
Swiss-port # P53350 Human Serine/threonine-protein kinase PLK1 Swiss-port # Q62673 Rat Serine/threonine-protein kinase PLK1 |
---|---|
Gene Symbol | PLK1 |
Gene Full Name | polo-like kinase 1 |
Background | Polo-like kinases are important regulators of cell cycle progression. PLK1 is a highly conserved Ser/Thr kinase that has essential roles in the formation of mitotic bipolar spindles (van Vugt et al., 2004). Deregulated expression of PLK’s is detected in many types of cancer and associated with oncogenesis (Takei et al., 2005). It has been proposed that PLK1 function is altered at different stages of mitosis through consecutive phosphorylation events at Ser137 and Thr210 (van de Weerdt et al., 2005). |
Research Area | Cancer antibody; Cell Biology and Cellular Response antibody; Gene Regulation antibody |
Calculated MW | 68 kDa |
PTM | Catalytic activity is enhanced by phosphorylation of Thr-210. Phosphorylation at Thr-210 is first detected on centrosomes in the G2 phase of the cell cycle, peaks in prometaphase and gradually disappears from centrosomes during anaphase. Dephosphorylation at Thr-210 at centrosomes is probably mediated by protein phosphatase 1C (PP1C), via interaction with PPP1R12A/MYPT1. Autophosphorylation and phosphorylation of Ser-137 may not be significant for the activation of PLK1 during mitosis, but may enhance catalytic activity during recovery after DNA damage checkpoint. Phosphorylated in vitro by STK10. Ubiquitinated by the anaphase promoting complex/cyclosome (APC/C) in anaphase and following DNA damage, leading to its degradation by the proteasome. Ubiquitination is mediated via its interaction with FZR1/CDH1. Ubiquitination and subsequent degradation prevents entry into mitosis and is essential to maintain an efficient G2 DNA damage checkpoint. Monoubiquitination at Lys-492 by the BCR(KLHL22) ubiquitin ligase complex does not lead to degradation: it promotes PLK1 dissociation from phosphoreceptor proteins and subsequent removal from kinetochores, allowing silencing of the spindle assembly checkpoint (SAC) and chromosome segregation. |